| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/ANNONC/MDJ073 |
| P8608 | Fatcat ID | release_cth45cjadbhyvn3fh3k24my5kq |
| P698 | PubMed publication ID | 16317014 |
| P5875 | ResearchGate publication ID | 7452040 |
| P2093 | author name string | D Watkins | |
| C Ryan | |||
| S Ashley | |||
| A Norton | |||
| K Priest | |||
| M E R O'Brien | |||
| N Rowell | |||
| R Sayer | |||
| C Corbishley | |||
| P433 | issue | 2 | |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 270-275 | |
| P577 | publication date | 2005-11-29 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial | |
| P2283 | uses | randomized experiment | Q1231081 |
| P478 | volume | 17 |
| Q52668368 | "The Less I Think About It, the Better I Feel": A Thematic Analysis of the Subjective Experience of Malignant Mesothelioma Patients and Their Caregivers. |
| Q47246911 | 'It's all bad news': the first 3 months following a diagnosis of malignant pleural mesothelioma. |
| Q30474771 | A 26-year-old male with mesothelioma due to asbestos exposure |
| Q38261500 | Advances in malignant peritoneal mesothelioma |
| Q37070229 | Advances in the systemic therapy of malignant pleural mesothelioma |
| Q30478994 | BTS statement on malignant mesothelioma in the UK, 2007. |
| Q55053946 | Biomarkers in malignant mesothelioma-an unfulfilled need or a waste of resources? |
| Q37090808 | Chemotherapy for malignant pleural mesothelioma: a review of current management and a look to the future |
| Q52672893 | Chemotherapy treatment in malignant pleural mesothelioma: a difficult history. |
| Q37817035 | Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment |
| Q83206656 | Early mesothelioma revisited |
| Q46221067 | Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial |
| Q58765920 | Early-stage Clinical Characterization of Malignant Pleural Mesothelioma |
| Q89676357 | Effusion cytology of malignant mesothelioma enables earlier diagnosis and recognizes patients with better prognosis |
| Q36758593 | Emerging drugs for mesothelioma |
| Q37449036 | Future developments in the management of malignant pleural mesothelioma |
| Q28394028 | Guidelines for the diagnosis and treatment of malignant pleural mesothelioma |
| Q53174194 | Lung cancer: from staging to treatment - a summary of an international meeting. |
| Q34513958 | Malignant pleural mesothelioma: an update on diagnosis and treatment options |
| Q36834027 | Malignant pleural mesothelioma: current concepts in treatment |
| Q38542421 | Medical and oncological management of malignant mesothelioma. |
| Q38476131 | Mesothelioma treatment |
| Q36905239 | Optimising survival in malignant mesothelioma |
| Q51045173 | Predictive factors analysis for malignant peritoneal mesothelioma. |
| Q51541835 | SEOM guidelines for the treatment of malignant pleural mesothelioma. |
| Q37079848 | Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology |
| Q37992694 | Systemic treatment of malignant pleural mesothelioma |
| Q37260408 | Systemic treatments for mesothelioma: standard and novel |
| Q59132459 | The use of patient-reported outcome measures (PROMs) in the management of malignant pleural mesothelioma: a descriptive literature survey |
| Q82061962 | [Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma] |
| Q80426618 | [Malignant pleural mesothelioma: interrogations and hopes concerning the expected epidemic] |
Search more.